-
Something wrong with this record ?
Functional cholinergic damage develops with amyloid accumulation in young adult APPswe/PS1dE9 transgenic mice
E. Machová, V. Rudajev, H. Smycková, H. Koivisto, H. Tanila, V. Dolezal,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Acetylcholine deficiency MeSH
- Alzheimer Disease genetics metabolism physiopathology MeSH
- Amyloid metabolism MeSH
- Amyloid beta-Protein Precursor genetics MeSH
- Cholinergic Agonists pharmacology MeSH
- Cholinergic Fibers metabolism pathology MeSH
- Nerve Degeneration metabolism pathology MeSH
- Down-Regulation genetics MeSH
- Hippocampus metabolism pathology physiopathology MeSH
- Disease Models, Animal MeSH
- Brain Chemistry genetics MeSH
- Brain growth & development metabolism physiopathology MeSH
- Cerebral Cortex growth & development metabolism physiopathology MeSH
- Mice, Transgenic MeSH
- Mice MeSH
- Organ Culture Techniques MeSH
- Presenilin-1 genetics MeSH
- GTP-Binding Proteins drug effects genetics metabolism MeSH
- Receptors, Muscarinic metabolism MeSH
- Aging metabolism MeSH
- Age Factors MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
We investigated the functional characteristics of pre- and postsynaptic cholinergic transmission in APPswe/PS1dE9 double transgenic mice at a young age (7-10 weeks) before the onset of amyloid plaque formation and at adult age (5-6 months) at its onset. We compared brain slices from cerebral cortex and hippocampus with amyloid deposits to slices from striatum with no amyloid plaques by 6 months of age. In young transgenic mice we found no impairments of preformed and newly synthesized [(3)H]-ACh release, indicating intact releasing machinery and release turnover, respectively. Adult transgenic mice displayed a significant increase in preformed [(3)H]-ACh release in cortex but a decrease in hippocampus and striatum. The extent of presynaptic muscarinic autoregulation was unchanged. Evoked release of newly synthesized [(3)H]-ACh was significantly reduced in the cortex and hippocampus but unchanged in the striatum. Carbachol-induced G-protein activation in cortical membranes displayed decreased potency but normal efficacy in adult animals and no changes in young animals. These results indicate that functional pre- and postsynaptic cholinergic deficits are not present in APPswe/PS1dE9 transgenic mice before 10 weeks of age, but develop along with beta-amyloid accumulation in the brain.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12025320
- 003
- CZ-PrNML
- 005
- 20130129171147.0
- 007
- ta
- 008
- 120816e20100104xxu f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.nbd.2009.12.023 $2 doi
- 035 __
- $a (PubMed)20053373
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Machová, Eva. $7 _AN045395 $u Institute of Physiology CAS, Vídenská 1083, 14220 Prague 4, Czech Republic.
- 245 10
- $a Functional cholinergic damage develops with amyloid accumulation in young adult APPswe/PS1dE9 transgenic mice / $c E. Machová, V. Rudajev, H. Smycková, H. Koivisto, H. Tanila, V. Dolezal,
- 520 9_
- $a We investigated the functional characteristics of pre- and postsynaptic cholinergic transmission in APPswe/PS1dE9 double transgenic mice at a young age (7-10 weeks) before the onset of amyloid plaque formation and at adult age (5-6 months) at its onset. We compared brain slices from cerebral cortex and hippocampus with amyloid deposits to slices from striatum with no amyloid plaques by 6 months of age. In young transgenic mice we found no impairments of preformed and newly synthesized [(3)H]-ACh release, indicating intact releasing machinery and release turnover, respectively. Adult transgenic mice displayed a significant increase in preformed [(3)H]-ACh release in cortex but a decrease in hippocampus and striatum. The extent of presynaptic muscarinic autoregulation was unchanged. Evoked release of newly synthesized [(3)H]-ACh was significantly reduced in the cortex and hippocampus but unchanged in the striatum. Carbachol-induced G-protein activation in cortical membranes displayed decreased potency but normal efficacy in adult animals and no changes in young animals. These results indicate that functional pre- and postsynaptic cholinergic deficits are not present in APPswe/PS1dE9 transgenic mice before 10 weeks of age, but develop along with beta-amyloid accumulation in the brain.
- 650 _2
- $a acetylcholin $x nedostatek $7 D000109
- 650 _2
- $a věkové faktory $7 D000367
- 650 _2
- $a stárnutí $x metabolismus $7 D000375
- 650 _2
- $a Alzheimerova nemoc $x genetika $x metabolismus $x patofyziologie $7 D000544
- 650 _2
- $a amyloid $x metabolismus $7 D000682
- 650 _2
- $a amyloidový prekurzorový protein beta $x genetika $7 D016564
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a mozek $x růst a vývoj $x metabolismus $x patofyziologie $7 D001921
- 650 _2
- $a mozek - chemie $x genetika $7 D001923
- 650 _2
- $a mozková kůra $x růst a vývoj $x metabolismus $x patofyziologie $7 D002540
- 650 _2
- $a cholinergní agonisté $x farmakologie $7 D018679
- 650 _2
- $a cholinergní vlákna $x metabolismus $x patologie $7 D002799
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a down regulace $x genetika $7 D015536
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a proteiny vázající GTP $x účinky léků $x genetika $x metabolismus $7 D019204
- 650 _2
- $a hipokampus $x metabolismus $x patologie $x patofyziologie $7 D006624
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši transgenní $7 D008822
- 650 _2
- $a degenerace nervu $x metabolismus $x patologie $7 D009410
- 650 _2
- $a orgánové kultury - kultivační techniky $7 D009924
- 650 _2
- $a presenilin-1 $x genetika $7 D053764
- 650 _2
- $a receptory muskarinové $x metabolismus $7 D011976
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1#
- $a Rudajev, Vladimír. $7 jo20211124170
- 700 1#
- $a Smyčková, Helena. $7 _AN070962
- 700 1_
- $a Koivisto, Henna
- 700 1_
- $a Tanila, Heikki
- 700 1_
- $a Doležal, Vladimír, $d 1952 červen 12.- $7 nlk19990073099
- 773 0_
- $w MED00008403 $t Neurobiology of disease $x 1095-953X $g Roč. 38, č. 1 (20100104), s. 27-35
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20053373 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120816 $b ABA008
- 991 __
- $a 20130129171311 $b ABA008
- 999 __
- $a ok $b bmc $g 947362 $s 782666
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 38 $c 1 $d 27-35 $e 20100104 $i 1095-953X $m Neurobiology of disease $n Neurobiol Dis $x MED00008403
- LZP __
- $a Pubmed-20120816/10/02